The aforementioned findings suggest that CG may exert its anti-AD effects through the PPARγ pathway, given that peroxisomes serve as the primary site for lipid metabolism, including long-chain fatty acid metabolism and phosphatidylcholine synthesis. This evidence concerns the gene PPARG and Alzheimer disease.